Quest Diagnostics Reports First Quarter 2024 Financial Results; Raises Guidance for Full Year 2024

Go back to Quest Diagnostics Reports First Quarter 2024 Financial Results; Raises Guidance for Full Year 2024
Quest Diagnostics (NYSE: DGX) Delayed: 197.18 +3.60 (1.86%)
Previous Close $193.58    52 Week High $86.85 
Open $195.78    52 Week Low $59.66 
Day High $197.79    P/E 37.13 
Day Low $194.15    EPS $5.31 
Volume 957,686